Research

published November 30, 2020
The combination of VENCLEXTA plus obinutuzumab will be available as a fixed duration therapy for previously un
published October 11, 2017
Written by Lucie van den Berg, Medical reporter, Herald Sun October 5, 2017 4:02pm   A RE-ENGINEERED canc
published October 11, 2017
$187,000 to $6.30: Turnbull drug subsidy gives hope to cancer sufferersWritten by Adam Gartrell, Health C
published April 19, 2017
Watch Australian Haematologist Con Tam talk about clinical trials investigating BGB-3111 in CLL and Waldenstro
published April 27, 2016
  Rethink on chemotherapy as Government funds new medicine to fight lymphoma Thousands of Australians
published April 22, 2016
PET Determines Effectiveness of Hodgkin Lymphoma Treatment – Patients with Hodgkin lymphoma (HL) who underg
published April 4, 2016
A new time-saving subcutaneous formulation of MabThera has been approved by the PBS in Australia for the treat
published April 1, 2016
EMA action brings Nivolumab closer to first hematology approval Click here to read more
published April 1, 2016
Booming knowledge of how geonomics works for Cutaneous T cell Lymphoma is likely to lead to new, more targeted
published March 18, 2016
NEW AGENTS TRANSFORM THE TREATMENT OF NHLClick here to read more Advances for Non Hodgkin Lymphoma
published March 9, 2016
Reduced Intensity Salvage Allo-HCT Effective for Follicular LymphomaReduced intensity allogeneic hematopoietic
published February 4, 2016
 CAR T-cell therapy poised to shift hematologic malignancies treatment paradigmClick here for more inform

Newsletter Sign Up

Contact Lymphoma Australia Today!

Cart
  • No products in the cart.